Advertisement

Intensive Care Medicine

, Volume 44, Issue 6, pp 742–759 | Cite as

A state of the art review on optimal practices to prevent, recognize, and manage complications associated with intravascular devices in the critically ill

  • Jean-François Timsit
  • Mark Rupp
  • Emilio Bouza
  • Vineet Chopra
  • Tarja Kärpänen
  • Kevin Laupland
  • Thiago Lisboa
  • Leonard Mermel
  • Olivier Mimoz
  • Jean-Jacques Parienti
  • Garyphalia Poulakou
  • Bertrand Souweine
  • Walter Zingg
Review

Abstract

Intravascular catheters are inserted into almost all critically ill patients. This review provides up-to-date insight into available knowledge on epidemiology and diagnosis of complications of central vein and arterial catheters in ICU. It discusses the optimal therapy of catheter-related infections and thrombosis. Prevention of complications is a multidisciplinary task that combines both improvement of the process of care and introduction of new technologies. We emphasize the main component of the prevention strategies that should be used in critical care and propose areas of future investigation in this field.

Keywords

Intravascular catheter Thrombosis Pulmonary emboli Sepsis Critically ill 

Notes

Compliance with ethical standards

Conflicts of interest

Dr. Chopra discloses receiving grant support from the Agency for Healthcare Quality and Research and honoraria for research talks as a visiting professor. Dr. Kärpänen has received honoraria to present at a symposium and attend an international conference supported by 3M. Since contributing to the manuscript, she has taken a Senior Clinical Research Specialist role at 3M Deutschland GmbH. Dr. Mermel has served as a consultant for Marvao Medical and Nobio. Dr. Mimoz received grant support from 3M and Carefusion-BD and honoraria for giving lectures from 3M and Carefusion-BD. Dr. Timsit received grant support from 3M and honoraria for giving lectures from 3M.

Supplementary material

134_2018_5212_MOESM1_ESM.docx (58 kb)
Supplementary material 1 (DOCX 58 kb)

References

  1. 1.
    Timsit JF, L’Heriteau F, Lepape A, Francais A, Ruckly S, Venier AG, Jarno P, Boussat S, Coignard B, Savey A (2012) A multicentre analysis of catheter-related infection based on a hierarchical model. Intensive Care Med 38(10):1662–1672PubMedCrossRefGoogle Scholar
  2. 2.
    de Lassence A, Timsit JF, Tafflet M, Azoulay E, Jamali S, Vincent F, Cohen Y, Garrouste-Orgeas M, Alberti C, Dreyfuss D (2006) Pneumothorax in the intensive care unit: incidence, risk factors, and outcome. Anesthesiology 104(1):5–13PubMedCrossRefGoogle Scholar
  3. 3.
    Siempos II, Kopterides P, Tsangaris I, Dimopoulou I, Armaganidis AE (2009) Impact of catheter-related bloodstream infections on the mortality of critically ill patients: a meta-analysis. Crit Care Med 37(7):2283–2289PubMedCrossRefGoogle Scholar
  4. 4.
    Soufir L, Timsit JF, Mahe C, Carlet J, Regnier B, Chevret S (1999) Attributable morbidity and mortality of catheter-related septicemia in critically ill patients: a matched, risk-adjusted, cohort study. Infect Control Hosp Epidemiol 20(6):396–401PubMedCrossRefGoogle Scholar
  5. 5.
    Nuckols TK, Keeler E, Morton SC, Anderson L, Doyle B, Booth M, Shanman R, Grein J, Shekelle P (2016) Economic evaluation of quality improvement interventions for bloodstream infections related to central catheters: a systematic review. JAMA InternMed 176(12):1843–1854Google Scholar
  6. 6.
    Pages J, Hazera P, Megarbane B, du Cheyron D, Thuong M, Dutheil JJ, Valette X, Fournel F, Mermel LA, Mira JP et al (2016) Comparison of alcoholic chlorhexidine and povidone-iodine cutaneous antiseptics for the prevention of central venous catheter-related infection: a cohort and quasi-experimental multicenter study. Intensive Care Med 42(9):1418–1426PubMedCrossRefGoogle Scholar
  7. 7.
    Lucet JC, Boudama L, Zahar JR, Schwebel C, Geffory A, Pease S, Herault MC, Haouache H, Adrie C, Thuong M et al (2010) Infectious risk associated with arterial catheters compared to central venous catheters. Crit Care Med 38(4):552–559CrossRefGoogle Scholar
  8. 8.
    Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, Sexton B, Hyzy R, Welsh R, Roth G et al (2006) An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 355(26):2725–2732PubMedCrossRefGoogle Scholar
  9. 9.
    Calvino-Gunther S, Schwebel C, Hamidfar-Roy R, Bonadona A, Lugosi M, Ara-Somohano C, Minet C, Potton L, Cartier JC, Vesin A et al (2016) Complications of intravascular catheters in ICU: definitions, incidence and severity. A randomized controlled trial comparing usual transparent dressings versus new-generation dressings (the advanced study). Intensive Care Med 42(11):1753–1765PubMedCrossRefGoogle Scholar
  10. 10.
    Minet C, Lugosi M, Savoye PY, Menez C, Ruckly S, Bonadona A, Schwebel C, Hamidfar-Roy R, Dumanoir P, Ara-Somohano C et al (2012) Pulmonary embolism in mechanically ventilated patients requiring computed tomography: prevalence, risk factors, and outcome. Crit Care Med 40(12):3202–3208PubMedCrossRefGoogle Scholar
  11. 11.
    Fletcher JJ, Wilson TJ, Rajajee V, Stetler WR Jr, Jacobs TL, Sheehan KM, Brown DL (2016) A randomized trial of central venous catheter type and thrombosis in critically ill neurologic patients. Neurocrit Care 25(1):20–28PubMedCrossRefGoogle Scholar
  12. 12.
    Chopra V, Priya A, Pekow PS, Thompson R, Flanders SA, Lindenauer PK (2016) Variation in prevalence and patterns of peripherally inserted central catheter use in adults hospitalized with pneumonia. J Hosp Med 11(8):568–575PubMedCrossRefGoogle Scholar
  13. 13.
    Pikwer A, Akeson J, Lindgren S (2012) Complications associated with peripheral or central routes for central venous cannulation. Anaesthesia 67(1):65–71PubMedCrossRefGoogle Scholar
  14. 14.
    Chopra V, Anand S, Hickner A, Buist M, Rogers MA, Saint S, Flanders SA (2013) Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis. Lancet 382(9889):311–325PubMedCrossRefGoogle Scholar
  15. 15.
    Chopra V, Flanders SA, Saint S, Woller SC, O’Grady NP, Safdar N, Trerotola SO, Saran R, Moureau N, Wiseman S et al (2015) The Michigan appropriateness guide for intravenous catheters (MAGIC): results from a multispecialty panel using the RAND/UCLA appropriateness method. Ann Intern Med 163(6 Suppl):S1–S40PubMedCrossRefGoogle Scholar
  16. 16.
    Chopra V, O’Horo JC, Rogers MA, Maki DG, Safdar N (2013) The risk of bloodstream infection associated with peripherally inserted central catheters compared with central venous catheters in adults: a systematic review and meta-analysis. Infect Control Hosp Epidemiol 34(9):908–918PubMedCrossRefGoogle Scholar
  17. 17.
    Truche AS, Darmon M, Bailly S, Clec’h C, Dupuis C, Misset B, Azoulay E, Schwebel C, Bouadma L, Kallel H et al (2016) Continuous renal replacement therapy versus intermittent hemodialysis in intensive care patients: impact on mortality and renal recovery. Intensive Care Med 42(9):1408–1417PubMedCrossRefGoogle Scholar
  18. 18.
    Parienti JJ, Thirion M, Megarbane B, Souweine B, Ouchikhe A, Polito A, Forel JM, Marque S, Misset B, Airapetian N et al (2008) Femoral versus jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial. JAMA 299(20):2413–2422PubMedCrossRefGoogle Scholar
  19. 19.
    Souweine B, Liotier J, Heng AE, Isnard M, Ackoundou-N’Guessan C, Deteix P, Traore O (2006) Catheter colonization in acute renal failure patients: comparison of central venous and dialysis catheters. Am J Kidney Dis 47(5):879–887PubMedCrossRefGoogle Scholar
  20. 20.
    Chua HR, Schneider AG, Sherry NL, Lotfy N, Chan MJ, Galtieri J, Wong GR, Lipcsey M, Matte Cde A, Collins A et al (2014) Initial and extended use of femoral versus nonfemoral double-lumen vascular catheters and catheter-related infection during continuous renal replacement therapy. Am J Kidney Dis 64(6):909–917PubMedCrossRefGoogle Scholar
  21. 21.
    Parienti JJ, Dugue AE, Daurel C, Mira JP, Megarbane B, Mermel LA, Daubin C, du Cheyron D (2010) Continuous renal replacement therapy may increase the risk of catheter infection. Clin J Am Soc Nephrol 5(8):1489–1496PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    Souweine B, Traore O, Aublet-Cuvelier B, Badrikian L, Bret L, Sirot J, Gazuy N, Laveran H, Deteix P (1999) Dialysis and central venous catheter infections in critically ill patients: results of a prospective study. Crit Care Med 27(11):2394–2398PubMedCrossRefGoogle Scholar
  23. 23.
    Coupez E, Timsit JF, Ruckly S, Schwebel C, Gruson D, Canet E, Klouche K, Argaud L, Bohe J, Garrouste-Orgeas M et al (2016) Guidewire exchange versus new site placement for temporary dialysis catheter insertion in ICU patients: is there a greater risk of colonization or dysfunction? Crit Care 20(1):230PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    Chatzinikolaou I, Finkel K, Hanna H, Boktour M, Foringer J, Ho T, Raad I (2003) Antibiotic-coated hemodialysis catheters for the prevention of vascular catheter-related infections: a prospective, randomized study. Am J Med 115(5):352–357PubMedCrossRefGoogle Scholar
  25. 25.
    Hermite L, Quenot JP, Nadji A, Barbar SD, Charles PE, Hamet M, Jacquiot N, Ghiringhelli F, Freysz M (2012) Sodium citrate versus saline catheter locks for non-tunneled hemodialysis central venous catheters in critically ill adults: a randomized controlled trial. Intensive Care Med 38(2):279–285PubMedCrossRefGoogle Scholar
  26. 26.
    Parienti JJ, Deryckere S, Megarbane B, Valette X, Seguin A, Sauneuf B, Mira JP, Souweine B, Cattoir V, Daubin C et al (2014) Quasi-experimental study of sodium citrate locks and the risk of acute hemodialysis catheter infection among critically ill patients. Antimicrob Agents Chemother 58(10):5666–5672PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    Souweine B, Lautrette A, Gruson D, Canet E, Klouche K, Argaud L, Bohe J, Garrouste-Orgeas M, Mariat C, Vincent F et al (2015) Ethanol lock and risk of hemodialysis catheter infection in critically ill patients. A randomized controlled trial. Am J Respir Crit Care Med 191(9):1024–1032PubMedCrossRefGoogle Scholar
  28. 28.
    Parienti JJ, Megarbane B, Fischer MO, Lautrette A, Gazui N, Marin N, Hanouz JL, Ramakers M, Daubin C, Mira JP et al (2010) Catheter dysfunction and dialysis performance according to vascular access among 736 critically ill adults requiring renal replacement therapy: a randomized controlled study. Crit Care Med 38(4):1118–1125PubMedCrossRefGoogle Scholar
  29. 29.
    Simon EM, Summers SM (2017) Vascular access complications: an emergency medicine approach. Emerg Med Clin N Am 35(4):771–788CrossRefGoogle Scholar
  30. 30.
    Traore O, Liotier J, Souweine B (2005) Prospective study of arterial and central venous catheter colonization and of arterial- and central venous catheter-related bacteremia in intensive care units. Crit Care Med 33(6):1276–1280PubMedCrossRefGoogle Scholar
  31. 31.
    Mermel LA (2011) What is the predominant source of intravascular catheter infections? Clin Infect Dis 52(2):211–212PubMedCrossRefGoogle Scholar
  32. 32.
    Beloin C, Fernandez-Hidalgo N, Lebeaux D (2017) Understanding biofilm formation in intravascular device-related infections. Intensive Care Med 43(3):443–446PubMedCrossRefGoogle Scholar
  33. 33.
    Flemming HC, Wingender J, Szewzyk U, Steinberg P, Rice SA, Kjelleberg S (2016) Biofilms: an emergent form of bacterial life. Nat Rev Microbiol 14(9):563–575PubMedCrossRefGoogle Scholar
  34. 34.
    Costerton JW, Stewart PS, Greenberg EP (1999) Bacterial biofilms: a common cause of persistent infections. Science 284(5418):1318–1322PubMedCrossRefGoogle Scholar
  35. 35.
    Raad II, Fang X, Keutgen XM, Jiang Y, Sherertz R, Hachem R (2008) The role of chelators in preventing biofilm formation and catheter-related bloodstream infections. Curr Opin Infect Dis 21(4):385–392PubMedCrossRefGoogle Scholar
  36. 36.
    Lin MY, Hota B, Khan YM, Woeltje KF, Borlawsky TB, Doherty JA, Stevenson KB, Weinstein RA, Trick WE (2010) Quality of traditional surveillance for public reporting of nosocomial bloodstream infection rates. JAMA 304(18):2035–2041PubMedCrossRefGoogle Scholar
  37. 37.
    Timsit JF, Lugosi M, Minet C, Schwebel C (2011) Should we still need to systematically perform catheter culture in the intensive care unit? Crit Care Med 39:1556–1558PubMedCrossRefGoogle Scholar
  38. 38.
    Shuman EK, Washer LL, Arndt JL, Zalewski CA, Hyzy RC, Napolitano LM, Chenoweth CE (2010) Analysis of central line-associated bloodstream infections in the intensive care unit after implementation of central line bundles. Infect Control Hosp Epidemiol 31(5):551–553PubMedCrossRefGoogle Scholar
  39. 39.
    Worth LJ, Brett J, Bull AL, McBryde ES, Russo PL, Richards MJ (2009) Impact of revising the national nosocomial infection surveillance system definition for catheter-related bloodstream infection in ICU: reproducibility of the National Healthcare Safety Network case definition in an Australian cohort of infection control professionals. Am J Infect Control 37(8):643–648PubMedCrossRefGoogle Scholar
  40. 40.
    Safdar N, Maki DG (2002) Inflammation at the insertion site is not predictive of catheter-related bloodstream infection with short-term, noncuffed central venous catheters. Crit Care Med 30(12):2632–2635PubMedCrossRefGoogle Scholar
  41. 41.
    Mimoz O, Lucet JC, Kerforne T, Pascal J, Souweine B, Goudet V, Mercat A, Bouadma L, Lasocki S, Alfandari S et al (2015) Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial trial. Lancet 386(10008):2069–2077PubMedCrossRefGoogle Scholar
  42. 42.
    Parienti JJ, Mongardon N, Megarbane B, Mira JP, Kalfon P, Gros A, Marque S, Thuong M, Pottier V, Ramakers M et al (2015) Intravascular complications of central venous catheterization by insertion site. N Engl J Med 373(13):1220–1229PubMedCrossRefGoogle Scholar
  43. 43.
    Timsit JF, Schwebel C, Bouadma L, Geffroy A, Garrouste-Orgeas M, Pease S, Herault MC, Haouache H, Calvino-Gunther S, Gestin B et al (2009) Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial. JAMA 301(12):1231–1241PubMedCrossRefGoogle Scholar
  44. 44.
    Sherertz RJ, Raad II, Belani A, Koo LC, Rand KH, Pickett DL, Straub SA, Fauerbach LL (1990) Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory. J Clin Microbiol 28(1):76–82PubMedPubMedCentralGoogle Scholar
  45. 45.
    Maki DG, Weise CE, Sarafin HW (1977) A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med 296(23):1305–1309PubMedCrossRefGoogle Scholar
  46. 46.
    Safdar N, Fine JP, Maki DG (2005) Meta-analysis: methods for diagnosing intravascular device-related bloodstream infection. Ann Intern Med 142(6):451–466PubMedCrossRefGoogle Scholar
  47. 47.
    Brun-Buisson C, Abrouk F, Legrand P, Huet Y, Larabi S, Rapin M (1987) Diagnosis of central venous catheter-related sepsis. Critical level of quantitative tip cultures. Arch Intern Med 147(5):873–877PubMedCrossRefGoogle Scholar
  48. 48.
    Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 49(1):1–45PubMedPubMedCentralCrossRefGoogle Scholar
  49. 49.
    Bouza E, Sousa D, Rodriguez-Creixems M, Lechuz JG, Munoz P (2007) Is the volume of blood cultured still a significant factor in the diagnosis of bloodstream infections? J Clin Microbiol 45(9):2765–2769PubMedPubMedCentralCrossRefGoogle Scholar
  50. 50.
    Slobbe L, El Barzouhi A, Boersma E, Rijnders BJ (2009) Comparison of the roll plate method to the sonication method to diagnose catheter colonization and bacteremia in patients with long-term tunnelled catheters: a randomized prospective study. J Clin Microbiol 47(4):885–888PubMedPubMedCentralCrossRefGoogle Scholar
  51. 51.
    Souweine B, Heng AE, Aumeran C, Thiolliere F, Gazuy N, Deteix P, Traore O (2008) Do antibiotics administered at the time of central venous catheter removal interfere with the evaluation of colonization? Intensive Care Med 34(2):286–291PubMedCrossRefGoogle Scholar
  52. 52.
    Vandecasteele SJ, Van Eldere J, Merckx R, Peetermans WE (2004) The effect of systemic antibiotics on the microbiological diagnosis of experimental foreign body infections caused by Staphylococcus epidermidis. Diagn Microbiol Infect Dis 48(2):89–95PubMedCrossRefGoogle Scholar
  53. 53.
    Rijnders BJ, Peetermans WE, Verwaest C, Wilmer A, Van Wijngaerden E (2004) Watchful waiting versus immediate catheter removal in ICU patients with suspected catheter-related infection: a randomized trial. Intensive Care Med 30(6):1073–1080PubMedCrossRefGoogle Scholar
  54. 54.
    Bouza E, Munoz P, Burillo A, Lopez-Rodriguez J, Fernandez-Perez C, Perez MJ, Rincon C (2005) The challenge of anticipating catheter tip colonization in major heart surgery patients in the intensive care unit: are surface cultures useful? Crit Care Med 33(9):1953–1960PubMedCrossRefGoogle Scholar
  55. 55.
    Fernandez-Cruz A, Martin-Rabadan P, Suarez-Salas M, Rojas-Wettig L, Perez MJ, Guinea J, Guembe M, Pelaez T, Sanchez-Carrillo C, Bouza E (2014) Is it feasible to diagnose catheter-related candidemia without catheter withdrawal? Med Mycol 52(5):491–497PubMedCrossRefGoogle Scholar
  56. 56.
    Blot F, Nitenberg G, Chachaty E, Raynard B, Germann N, Antoun S, Laplanche A, Brun-Buisson C, Tancrede C (1999) Diagnosis of catheter-related bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures. Lancet 354(9184):1071–1077PubMedCrossRefGoogle Scholar
  57. 57.
    Raad I, Hanna HA, Alakech B, Chatzinikolaou I, Johnson MM, Tarrand J (2004) Differential time to positivity: a useful method for diagnosing catheter-related bloodstream infections. Ann Intern Med 140(1):18–25PubMedCrossRefGoogle Scholar
  58. 58.
    Bouza E, Alvarado N, Alcala L, Sanchez-Conde M, Perez MJ, Munoz P, Martin-Rabadan P, Rodriguez-Creixems M (2005) A prospective, randomized, and comparative study of 3 different methods for the diagnosis of intravascular catheter colonization. Clin Infect Dis 40(8):1096–1100PubMedCrossRefGoogle Scholar
  59. 59.
    Catton JA, Dobbins BM, Kite P, Wood JM, Eastwood K, Sugden S, Sandoe JA, Burke D, McMahon MJ, Wilcox MH (2005) In situ diagnosis of intravascular catheter-related bloodstream infection: a comparison of quantitative culture, differential time to positivity, and endoluminal brushing. Crit Care Med 33(4):787–791PubMedCrossRefGoogle Scholar
  60. 60.
    Guembe M, Rodriguez-Creixems M, Sanchez-Carrillo C, Perez-Parra A, Martin-Rabadan P, Bouza E (2010) How many lumens should be cultured in the conservative diagnosis of catheter-related bloodstream infections? Clin Infect Dis 50(12):1575–1579PubMedCrossRefGoogle Scholar
  61. 61.
    Bouza E, Martin-Rabadan P, Echenagusia A, Camunez F, Rodriguez-Rosales G, Simo G, Echenagusia M, Guembe M (2014) Diagnosis of venous access port colonization requires cultures from multiple sites: should guidelines be amended? Diagn Microbiol Infect Dis 78(2):162–167PubMedCrossRefGoogle Scholar
  62. 62.
    Rijnders BJ, Van Wijngaerden E, Peetermans WE (2002) Catheter-tip colonization as a surrogate end point in clinical studies on catheter-related bloodstream infection: how strong is the evidence? Clin Infect Dis 35(9):1053–1058PubMedCrossRefGoogle Scholar
  63. 63.
    Mrozec N, Lautrette A, Aumeran C, Laurichesse H, Forestier C, Traore O, Souweine B (2011) Bloodstream infection following positive catheter cultures, what are the risks in the ICU when catheters are routinely cultured upon removal? Crit Care Med 39(6):1301–1305CrossRefGoogle Scholar
  64. 64.
    Timsit JF, Mimoz O, Mourvillier B, Souweine B, Garrouste-Orgeas M, Alfandari S, Plantefeve G, Bronchard R, Troche G, Gauzit R et al (2012) Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults. Am J Respir Crit Care Med 186(12):1272–1278PubMedCrossRefGoogle Scholar
  65. 65.
    Zafar U, Riederer K, Khatib R, Szpunar S, Sharma M (2009) Relevance of isolating Staphylococcus aureus from intravascular catheters without positive blood culture. J Hosp Infect 71(2):193–195PubMedCrossRefGoogle Scholar
  66. 66.
    Ruhe JJ, Menon A (2006) Clinical significance of isolated Staphylococcus aureus central venous catheter tip cultures. Clin Microbiol Infect 12(9):933–936PubMedCrossRefGoogle Scholar
  67. 67.
    Ekkelenkamp MB, van der Bruggen T, van de Vijver DA, Wolfs TF, Bonten MJ (2008) Bacteremic complications of intravascular catheters colonized with Staphylococcus aureus. Clin Infect Dis 46(1):114–118PubMedCrossRefGoogle Scholar
  68. 68.
    Timsit JF, Farkas JC, Boyer JM, Martin JB, Misset B, Renaud B, Carlet J (1998) Central vein catheter-related thrombosis in intensive care patients: incidence, risks factors, and relationship with catheter-related sepsis. Chest 114(1):207–213PubMedCrossRefGoogle Scholar
  69. 69.
    Akova M, Daikos GL, Tzouvelekis L, Carmeli Y (2012) Interventional strategies and current clinical experience with carbapenemase-producing gram-negative bacteria. Clin Microbiol Infect 18(5):439–448PubMedCrossRefGoogle Scholar
  70. 70.
    Lorente L, Jimenez A, Santana M, Iribarren JL, Jimenez JJ, Martin MM, Mora ML (2007) Microorganisms responsible for intravascular catheter-related bloodstream infection according to the catheter site. Crit Care Med 35(10):2424–2427PubMedCrossRefGoogle Scholar
  71. 71.
    Safdar N, Handelsman J, Maki DG (2004) Does combination antimicrobial therapy reduce mortality in gram-negative bacteraemia? A meta-analysis. Lancet Infect Dis 4(8):519–527PubMedCrossRefGoogle Scholar
  72. 72.
    Cornely OA, Bassetti M, Calandra T, Garbino J, Kullberg BJ, Lortholary O, Meersseman W, Akova M, Arendrup MC, Arikan-Akdagli S et al (2012) ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect 18(Suppl 7):19–37PubMedCrossRefGoogle Scholar
  73. 73.
    Merrer J, De Jonghe B, Golliot F, Lefrant JY, Raffy B, Barre E, Rigaud JP, Casciani D, Misset B, Bosquet C et al (2001) Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. JAMA 286(6):700–707PubMedCrossRefGoogle Scholar
  74. 74.
    O’Horo JC, Maki DG, Krupp AE, Safdar N (2014) Arterial catheters as a source of bloodstream infection: a systematic review and meta-analysis. Crit Care Med 42(6):1334–1339PubMedCrossRefGoogle Scholar
  75. 75.
    Brass P, Hellmich M, Kolodziej L, Schick G, Smith AF (2015) Ultrasound guidance versus anatomical landmarks for internal jugular vein catheterization. Cochrane Database Syst Rev 1:CD006962PubMedGoogle Scholar
  76. 76.
    Brass P, Hellmich M, Kolodziej L, Schick G, Smith AF (2015) Ultrasound guidance versus anatomical landmarks for subclavian or femoral vein catheterization. Cochrane Database Syst Rev 1:CD011447PubMedGoogle Scholar
  77. 77.
    Milling TJ Jr, Rose J, Briggs WM, Birkhahn R, Gaeta TJ, Bove JJ, Melniker LA (2005) Randomized, controlled clinical trial of point-of-care limited ultrasonography assistance of central venous cannulation: the third sonography outcomes assessment program (SOAP-3) trial. Crit Care Med 33(8):1764–1769PubMedCrossRefGoogle Scholar
  78. 78.
    Li J, Fan YY, Xin MZ, Yan J, Hu W, Huang WH, Lin XL, Qin HY (2014) A randomised, controlled trial comparing the long-term effects of peripherally inserted central catheter placement in chemotherapy patients using B-mode ultrasound with modified Seldinger technique versus blind puncture. Eur J Oncol Nurs 18(1):94–103PubMedCrossRefGoogle Scholar
  79. 79.
    Soni NJ, Reyes LF, Keyt H, Arango A, Gelfond JA, Peters JI, Levine SM, Adams SG, Restrepo MI (2016) Use of ultrasound guidance for central venous catheterization: a national survey of intensivists and hospitalists. J Crit Care 36:277–283PubMedCrossRefGoogle Scholar
  80. 80.
    Mimoz O, Chopra V, Timsit JF (2016) What’s new in catheter-related infection: skin cleansing and skin antisepsis. Intensive Care Med 42(11):1784–1786PubMedCrossRefGoogle Scholar
  81. 81.
    Casey AL, Badia JM, Higgins A, Korndorffer J, Mantyh C, Mimoz O, Moro M (2017) Skin antisepsis: it’s not only what you use, it’s the way that you use it. J Hosp Infect 96(3):221–222PubMedCrossRefGoogle Scholar
  82. 82.
    Mimoz O, Chopra V, Widmer A (2016) What’s new in skin antisepsis for short-term intravascular catheters: new data to address old problems? Intensive Care Med 42(12):2043–2045PubMedCrossRefGoogle Scholar
  83. 83.
    Wang JT, Sheng WH, Wang JL, Chen D, Chen ML, Chen YC, Chang SC (2008) Longitudinal analysis of chlorhexidine susceptibilities of nosocomial methicillin-resistant Staphylococcus aureus isolates at a teaching hospital in Taiwan. J Antimicrob Chemother 62(3):514–517PubMedCrossRefGoogle Scholar
  84. 84.
    Lee AS, Macedo-Vinas M, Francois P, Renzi G, Schrenzel J, Vernaz N, Pittet D, Harbarth S (2011) Impact of combined low-level mupirocin and genotypic chlorhexidine resistance on persistent methicillin-resistant Staphylococcus aureus carriage after decolonization therapy: a case-control study. Clin Infect Dis 52(12):1422–1430PubMedCrossRefGoogle Scholar
  85. 85.
    Bouadma L, Karpanen T, Elliott T (2018) Chlorhexidine use in adult patients on ICU. Intensive Care Med.  https://doi.org/10.1007/s00134-018-5137-5 CrossRefPubMedGoogle Scholar
  86. 86.
    Climo MW, Yokoe DS, Warren DK, Perl TM, Bolon M, Herwaldt LA, Weinstein RA, Sepkowitz KA, Jernigan JA, Sanogo K et al (2013) Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med 368(6):533–542PubMedPubMedCentralCrossRefGoogle Scholar
  87. 87.
    Huang SS, Septimus E, Kleinman K, Moody J, Hickok J, Avery TR, Lankiewicz J, Gombosev A, Terpstra L, Hartford F et al (2013) Targeted versus universal decolonization to prevent ICU infection. N Engl J Med 368(24):2255–2265PubMedCrossRefGoogle Scholar
  88. 88.
    Milstone AM, Elward A, Song X, Zerr DM, Orscheln R, Speck K, Obeng D, Reich NG, Coffin SE, Perl TM (2013) Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: a multicentre, cluster-randomised, crossover trial. Lancet 381(9872):1099–1106PubMedPubMedCentralCrossRefGoogle Scholar
  89. 89.
    Afonso E, Blot K, Blot S (2016) Prevention of hospital-acquired bloodstream infections through chlorhexidine gluconate-impregnated washcloth bathing in intensive care units: a systematic review and meta-analysis of randomised crossover trials. Euro Surveill.  https://doi.org/10.2807/1560-7917.ES.2016.21.46.30400 PubMedPubMedCentralCrossRefGoogle Scholar
  90. 90.
    Centers for Disease Control and Prevention. 2017 updated recommendations on the use of chlorhexidine-impregnated dressings for prevention of intravascular catheter-related infections. https://www.cdc.gov/infectioncontrol/guidelines/pdf/bsi/c-i-dressings-H.pdf. Accessed 10 May 2018
  91. 91.
    Hockenhull JC, Dwan KM, Smith GW, Gamble CL, Boland A, Walley TJ, Dickson RC (2009) The clinical effectiveness of central venous catheters treated with anti-infective agents in preventing catheter-related bloodstream infections: a systematic review. Crit Care Med 37(2):702–712PubMedCrossRefGoogle Scholar
  92. 92.
    Falagas ME, Fragoulis K, Bliziotis IA, Chatzinikolaou I (2007) Rifampicin-impregnated central venous catheters: a meta-analysis of randomized controlled trials. J Antimicrob Chemother 59(3):359–369PubMedCrossRefGoogle Scholar
  93. 93.
    Ramos ER, Reitzel R, Jiang Y, Hachem RY, Chaftari AM, Chemaly RF, Hackett B, Pravinkumar SE, Nates J, Tarrand JJ et al (2011) Clinical effectiveness and risk of emerging resistance associated with prolonged use of antibiotic-impregnated catheters: more than 0.5 million catheter days and 7 years of clinical experience. Crit Care Med.  https://doi.org/10.1097/CCM.0b013e3181feb83e PubMedCrossRefGoogle Scholar
  94. 94.
    Zacharioudakis IM, Zervou FN, Arvanitis M, Ziakas PD, Mermel LA, Mylonakis E (2014) Antimicrobial lock solutions as a method to prevent central line-associated bloodstream infections: a meta-analysis of randomized controlled trials. Clin Infect Dis 59(12):1741–1749PubMedCrossRefGoogle Scholar
  95. 95.
    Landry DL, Braden GL, Gobeille SL, Haessler SD, Vaidya CK, Sweet SJ (2010) Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis. Clin J Am Soc Nephrol 5(10):1799–1804PubMedPubMedCentralCrossRefGoogle Scholar
  96. 96.
    Hemmelgarn BR, Manns BJ, Soroka SD, Levin A, MacRae J, Tennankore K, Wilson JS, Weaver RG, Ravani P, Quinn RR et al (2018) Effectiveness and cost of weekly recombinant tissue plasminogen activator hemodialysis catheter locking solution. Clin J Am Soc Nephrol.  https://doi.org/10.2215/CJN.08510817 CrossRefPubMedGoogle Scholar
  97. 97.
    Longo R, Llorens M, Goetz C, Platini C, Eid N, Sellies J, Ouamara N, Quetin P (2017) Taurolidine/citrate lock therapy for primary prevention of catheter-related infections in cancer patients: results of a prospective, randomized, phase IV trial (ATAPAC). Oncology 93(2):99–105PubMedCrossRefGoogle Scholar
  98. 98.
    Zhao Y, Li Z, Zhang L, Yang J, Yang Y, Tang Y, Fu P (2014) Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials. Am J Kidney Dis 63(3):479–490PubMedCrossRefGoogle Scholar
  99. 99.
    Correa Barcellos F, Nunes BP, Valle LJ, Lopes T, Orlando B, Scherer C, Nunes M, Araujo Duarte G, Bohlke M (2017) Comparative effectiveness of 30% trisodium citrate and heparin lock solution in preventing infection and dysfunction of hemodialysis catheters: a randomized controlled trial (CITRIM trial). Infection 45(2):139–145PubMedCrossRefGoogle Scholar
  100. 100.
    Tribler S, Brandt CF, Petersen AH, Petersen JH, Fuglsang KA, Staun M, Broebech P, Moser CE, Jeppesen PB (2017) Taurolidine-citrate-heparin lock reduces catheter-related bloodstream infections in intestinal failure patients dependent on home parenteral support: a randomized, placebo-controlled trial. Am J Clin Nutr 106(3):839–848PubMedGoogle Scholar
  101. 101.
    Bruyere R, Soudry-Faure A, Capellier G, Binquet C, Nadji A, Torner S, Blasco G, Yannaraki M, Barbar SD, Quenot JP (2014) Comparison of heparin to citrate as a catheter locking solution for non-tunneled central venous hemodialysis catheters in patients requiring renal replacement therapy for acute renal failure (VERROU-REA study): study protocol for a randomized controlled trial. Trials 15:449PubMedPubMedCentralCrossRefGoogle Scholar
  102. 102.
    Raad II, Luna M, Khalil SA, Costerton JW, Lam C, Bodey GP (1994) The relationship between the thrombotic and infectious complications of central venous catheters. JAMA 271(13):1014–1016PubMedCrossRefGoogle Scholar
  103. 103.
    Timsit JF, Bruneel F, Cheval C, Mamzer MF, Garrouste-Orgeas M, Wolff M, Misset B, Chevret S, Regnier B, Carlet J (1999) Use of tunneled femoral catheters to prevent catheter-related infection. A randomized, controlled trial. Ann Intern Med 130(9):729–735PubMedCrossRefGoogle Scholar
  104. 104.
    Chopra V, Kaatz S, Conlon A, Paje D, Grant PJ, Rogers MAM, Bernstein SJ, Saint S, Flanders SA (2017) The Michigan risk score to predict peripherally inserted central catheter-associated thrombosis. J Thromb Haemost 15(10):1951–1962PubMedCrossRefGoogle Scholar
  105. 105.
    Zhong L, Wang HL, Xu B, Yuan Y, Wang X, Zhang YY, Ji L, Pan ZM, Hu ZS (2017) Normal saline versus heparin for patency of central venous catheters in adult patients—a systematic review and meta-analysis. Crit Care 21(1):5PubMedPubMedCentralCrossRefGoogle Scholar
  106. 106.
    Akl EA, Ramly EP, Kahale LA, Yosuico VE, Barba M, Sperati F, Cook D, Schunemann H (2014) Anticoagulation for people with cancer and central venous catheters. Cochrane Database Syst Rev.  https://doi.org/10.1002/14651858.CD006468.pub5/full CrossRefPubMedGoogle Scholar
  107. 107.
    van Miert C, Hill R, Jones L (2012) Interventions for restoring patency of occluded central venous catheter lumens. Cochrane Database Syst Rev.  https://doi.org/10.1002/14651858.CD007119.pub2 PubMedCrossRefGoogle Scholar
  108. 108.
    Ernst FR, Chen E, Lipkin C, Tayama D, Amin AN (2014) Comparison of hospital length of stay, costs, and readmissions of alteplase versus catheter replacement among patients with occluded central venous catheters. J Hosp Med 9(8):490–496PubMedPubMedCentralCrossRefGoogle Scholar
  109. 109.
    Marang-van de Mheen PJ, van Bodegom-Vos L (2016) Meta-analysis of the central line bundle for preventing catheter-related infections: a case study in appraising the evidence in quality improvement. BMJ Qual Saf 25(2):118–129PubMedCrossRefGoogle Scholar
  110. 110.
    Furuya EY, Dick A, Perencevich EN, Pogorzelska M, Goldmann D, Stone PW (2011) Central line bundle implementation in US intensive care units and impact on bloodstream infections. PLoS One 6(1):e15452PubMedPubMedCentralCrossRefGoogle Scholar
  111. 111.
    Weaver SJ, Weeks K, Pham JC, Pronovost PJ (2014) On the CUSP: stop BSI: evaluating the relationship between central line-associated bloodstream infection rate and patient safety climate profile. Am J Infect Control 42(10 Suppl):S203–S208PubMedPubMedCentralCrossRefGoogle Scholar
  112. 112.
    Pronovost PJ, Weaver SJ, Berenholtz SM, Lubomski LH, Maragakis LL, Marsteller JA, Pham JC, Sawyer MD, Thompson DA, Weeks K et al (2017) Reducing preventable harm: observations on minimizing bloodstream infections. J Health Organ Manag 31(1):2–9PubMedCrossRefGoogle Scholar
  113. 113.
    O’Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, Lipsett PA, Masur H, Mermel LA, Pearson ML et al (2011) Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 52(9):e162–e193PubMedPubMedCentralCrossRefGoogle Scholar
  114. 114.
    Loveday HP, Wilson JA, Prieto J, Wilcox MH (2016) epic3: revised recommendation for intravenous catheter and catheter site care. J Hosp Infect 92(4):346–348PubMedCrossRefGoogle Scholar
  115. 115.
    Marschall J, Mermel LA, Fakih M, Hadaway L, Kallen A, O’Grady NP, Pettis AM, Rupp ME, Sandora T, Maragakis LL et al (2014) Strategies to prevent central line-associated bloodstream infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 35(7):753–771PubMedCrossRefGoogle Scholar
  116. 116.
    Shapey IM, Foster MA, Whitehouse T, Jumaa P, Bion JF (2009) Central venous catheter-related bloodstream infections: improving post-insertion catheter care. J Hosp Infect 71(2):117–122PubMedCrossRefGoogle Scholar
  117. 117.
    Timsit JF, Bouadma L, Ruckly S, Schwebel C, Garrouste-Orgeas M, Bronchard R, Calvino-Gunther S, Laupland K, Adrie C, Thuong M et al (2012) Dressing disruption is a major risk factor for catheter-related infections. Crit Care Med 40(6):1707–1714PubMedCrossRefGoogle Scholar
  118. 118.
    Ista E, van der Hoven B, Kornelisse RF, van der Starre C, Vos MC, Boersma E, Helder OK (2016) Effectiveness of insertion and maintenance bundles to prevent central-line-associated bloodstream infections in critically ill patients of all ages: a systematic review and meta-analysis. Lancet Infect Dis 16(6):724–734PubMedCrossRefGoogle Scholar
  119. 119.
    Nicol PW, Watkins RE, Donovan RJ, Wynaden D, Cadwallader H (2009) The power of vivid experience in hand hygiene compliance. J Hosp Infect 72(1):36–42PubMedCrossRefGoogle Scholar
  120. 120.
    Zingg W, Holmes A, Dettenkofer M, Goetting T, Secci F, Clack L, Allegranzi B, Magiorakos AP, Pittet D (2015) Hospital organisation, management, and structure for prevention of health-care-associated infection: a systematic review and expert consensus. Lancet Infect Dis 15(2):212–224PubMedCrossRefGoogle Scholar
  121. 121.
    Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC (2009) Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci 4:50PubMedPubMedCentralCrossRefGoogle Scholar
  122. 122.
    Blot K, Bergs J, Vogelaers D, Blot S, Vandijck D (2014) Prevention of central line-associated bloodstream infections through quality improvement interventions: a systematic review and meta-analysis. Clin Infect Dis 59(1):96–105PubMedPubMedCentralCrossRefGoogle Scholar
  123. 123.
    van der Kooi T, Sax H, Pittet D, van Dissel J, van Benthem B, Walder B, Cartier V, Clack L, de Greeff S, Wolkewitz M et al (2017) Prevention of hospital infections by intervention and training (PROHIBIT): results of a pan-European cluster-randomized multicentre study to reduce central venous catheter-related bloodstream infections. Intensive Care Med.  https://doi.org/10.1007/s00134-017-5007-6 PubMedCrossRefGoogle Scholar
  124. 124.
    Zingg W, Cartier V, Inan C, Touveneau S, Theriault M, Gayet-Ageron A, Clergue F, Pittet D, Walder B (2014) Hospital-wide multidisciplinary, multimodal intervention programme to reduce central venous catheter-associated bloodstream infection. PLoS One 9(4):e93898PubMedPubMedCentralCrossRefGoogle Scholar
  125. 125.
    Langgartner J, Linde HJ, Lehn N, Reng M, Scholmerich J, Gluck T (2004) Combined skin disinfection with chlorhexidine/propanol and aqueous povidone-iodine reduces bacterial colonisation of central venous catheters. Intensive Care Med 30(6):1081–1088PubMedCrossRefGoogle Scholar
  126. 126.
    Patrick S, McDowell A, Lee A, Frau A, Martin U, Gardner E, McLorinan G, Eames N (2017) Antisepsis of the skin before spinal surgery with povidone iodine-alcohol followed by chlorhexidine gluconate-alcohol versus povidone iodine-alcohol applied twice for the prevention of contamination of the wound by bacteria: a randomised controlled trial. Bone Joint J 99(10):1354–1365PubMedCrossRefGoogle Scholar
  127. 127.
    Corley A, Cantara M, Gardner J, Trexler P, Rock C, Maragakis LL (2017) Central line-associated bloodstream infection rate elevation: attributable to National Healthcare Safety Network surveillance definition changes, ongoing opportunities for infection prevention, or both? Am J Infect Control 45(9):1030–1032PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature and ESICM 2018

Authors and Affiliations

  • Jean-François Timsit
    • 1
    • 2
  • Mark Rupp
    • 3
    • 4
  • Emilio Bouza
    • 5
    • 6
    • 7
  • Vineet Chopra
    • 8
  • Tarja Kärpänen
    • 9
  • Kevin Laupland
    • 10
  • Thiago Lisboa
    • 11
    • 12
  • Leonard Mermel
    • 13
    • 14
  • Olivier Mimoz
    • 15
    • 16
    • 17
  • Jean-Jacques Parienti
    • 18
    • 19
  • Garyphalia Poulakou
    • 20
  • Bertrand Souweine
    • 21
    • 22
  • Walter Zingg
    • 23
  1. 1.Université Paris Diderot/Hopital Bichat - Réanimation Medicale et des maladies infectieusesParisFrance
  2. 2.UMR 1137 - IAME Team 5 – DeSCID: Decision Sciences in Infectious DiseasesControl and care Inserm/Univ Paris DiderotParisFrance
  3. 3.Division of Infectious DiseasesUniversity of Nebraska Medical CenterOmahaUSA
  4. 4.Department of Infection Control and EpidemiologyNebraska MedicineOmahaUSA
  5. 5.Medicine Department, School of MedicineUniversidad Complutense de Madrid (UCM)MadridSpain
  6. 6.Department of Clinical Microbiology and Infectious DiseasesHospital General Universitario Gregorio MarañónMadridSpain
  7. 7.Instituto de Investigación Sanitaria Gregorio MarañónMadridSpain
  8. 8.Division of Hospital Medicine, Department of Medicine, Patient Safety Enhancement Program and Center for Clinical Management ResearchUniversity of MichiganAnn ArborUSA
  9. 9.Department of Clinical Microbiology, University Hospitals Birmingham NHS Foundation TrustQueen Elizabeth HospitalBirminghamUK
  10. 10.Department of MedicineRoyal Inland HospitalKamloopsCanada
  11. 11.Rede Institucional de Pesquisa e Inovação em Medicina Intensiva, Complexo Hospitalar Santa Casa de Misericordia de Porto AlegrePorto AlegreBrazil
  12. 12.Critical Care Department and Infection Control CommitteeHospital de Clinicas de Porto AlegrePorto AlegreBrazil
  13. 13.Department of Medicine, Alpert Medical School of Brown UniversityRhode Island HospitalProvidenceUSA
  14. 14.Division of Infectious Diseases and Department of Epidemiology and Infection ControlRhode Island HospitalProvidenceUSA
  15. 15.Service des Urgences-SAMU 86CHU de PoitiersPoitiersFrance
  16. 16.Université de Poitiers, UFR de Médecine PharmaciePoitiersFrance
  17. 17.INSERM U1070, Pharmacologie des Agents antiInfectieuxPoitiersFrance
  18. 18.Department of Biostatistics and Clinical ResearchCentre Hospitalier Universitaire (CHU)CaenFrance
  19. 19.INSERM Unité Mixte de Recherche Scientifique 1075 COMETE (N.T.) and EA4655 Risques MicrobiensCaenFrance
  20. 20.4th Department of Internal MedicineAttikon University General Hospital, Athens University School of MedicineAthensGreece
  21. 21.Service de Réanimation MédicaleHôpital Gabriel Montpied, CHU de Clermont-FerrandClermont-FerrandFrance
  22. 22.Université Clermont Auvergne, CNRS, LMGEClermont-FerrandFrance
  23. 23.Infection Control Program and WHO Collaborating Centre for Patient SafetyUniversity of Geneva HospitalsGenevaSwitzerland

Personalised recommendations